These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15227294)

  • 41. Electrophysiologic testing: predictive of amiodarone efficacy in recurrent sustained ventricular tachycardia?
    Mas IJ; Massumi A; Harlan M; Seger JJ; Hall RJ
    Tex Heart Inst J; 1987 Dec; 14(4):382-8. PubMed ID: 15227294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
    Saksena S; Rothbart ST; Shah Y; Cappello G
    Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
    Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of chronic amiodarone therapy on ventricular tachycardia induced by programmed ventricular stimulation.
    DiCarlo LA; Morady F; de Buitleir M; Baerman JM; Schurig L; Annesley T
    Am Heart J; 1987 Jan; 113(1):57-64. PubMed ID: 3799442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amiodarone-induced ventricular fibrillation.
    McComb JM; Logan KR; Khan MM; Geddes JS; Adgey AA
    Eur J Cardiol; 1980; 11(5):381-5. PubMed ID: 7398728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
    Hamer AW; Finerman WB; Peter T; Mandel WJ
    Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
    Podrid PJ; Lown B
    Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
    Nademanee K; Hendrickson J; Kannan R; Singh BN
    Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
    N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.
    Kaski JC; Girotti LA; Messuti H; Rutitzky B; Rosenbaum MB
    Circulation; 1981 Aug; 64(2):273-9. PubMed ID: 6788399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart.
    Shenasa M; Denker S; Mahmud R; Lehmann M; Estrada A; Akhtar M
    J Am Coll Cardiol; 1984 Jul; 4(1):105-10. PubMed ID: 6736436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of intravenous amiodarone in patients with inducible repetitive ventricular responses and ventricular tachycardia.
    Hariman RJ; Gomes JA; Kang PS; El-Sherif N
    Am Heart J; 1984 Jun; 107(6):1109-17. PubMed ID: 6720537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
    Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB
    J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ventricular arrhythmias: use of electrophysiologic studies.
    Horowitz LN; Spielman SR; Greenspan AM; Webb CR; Kay HR
    Am Heart J; 1983 Oct; 106(4 Pt 2):881-6. PubMed ID: 6613834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
    Zipes DP; Prystowsky EN; Heger JJ
    J Am Coll Cardiol; 1984 Apr; 3(4):1059-71. PubMed ID: 6368644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
    Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA
    Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.